NR3C2 has been described as a tumor suppressor in multiple malignancies, such as pancreatic, lung, colon, and renal cancers [57]; however, the prognostic value and biological effect of low NR3C2 level in BC remains unclear [58]. The gene discussed is NR3C2; the disease is renal carcinoma.